SCHEMBL18896005

SCHEMBL18896005

CCN(CC/C=C1\C2=CC=CNC2COc2ccc(C(C)(C)O)cc21)CCN(CC)c1ccc(Cl)cc1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12121700 0.79 CYP19A1 (0.31) —
SCHEMBL18895962 0.78 CCR1 (0.39) CCR1
SCHEMBL10288001 0.76 CCR1 (0.56) CCR1
SCHEMBL652907 0.76 CCR1 (0.56) CCR1
SCHEMBL18633820 0.76 CCR1 (0.37) CCR1
SCHEMBL14579592 0.75 CCR1 (0.35) CCR1
SCHEMBL15478375 0.75 CCR1 (0.50) CCR1
SCHEMBL18633827 0.74 CCR1 (0.39) CCR1
SCHEMBL14420045 0.74 CCR1 (0.40) CCR1
SCHEMBL18895956 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9663537-B2 Chemokine receptor antagonists and methods of use MILLENNIUM PHARMACEUTICALS, INC. (US) 2017-05-30 — — US disclosed
Send feedback